Annual Total Expenses
$25.87 M
-$1.78 M-6.45%
December 31, 2023
Summary
- As of February 12, 2025, CYCC annual total expenses is $25.87 million, with the most recent change of -$1.78 million (-6.45%) on December 31, 2023.
- During the last 3 years, CYCC annual total expenses has risen by +$15.24 million (+143.26%).
- CYCC annual total expenses is now -99.61% below its all-time high of $6.70 billion, reached on January 1, 1994.
Performance
CYCC Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$2.19 M
-$1.46 M-40.05%
September 30, 2024
Summary
- As of February 12, 2025, CYCC quarterly total expenses is $2.19 million, with the most recent change of -$1.46 million (-40.05%) on September 30, 2024.
- Over the past year, CYCC quarterly total expenses has dropped by -$3.20 million (-59.43%).
- CYCC quarterly total expenses is now -84.05% below its all-time high of $13.71 million, reached on September 30, 2008.
Performance
CYCC Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CYCC Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | -59.4% |
| 3 y3 years | +143.3% | -70.1% |
| 5 y5 years | +166.8% | -70.1% |
CYCC Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +15.6% | -75.3% | at low |
| 5 y | 5-year | -6.5% | +167.2% | -75.3% | at low |
| alltime | all time | -99.6% | +172.6% | -84.0% | +133.2% |
Cyclacel Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.19 M(-40.0%) |
| Jun 2024 | - | $3.65 M(-16.8%) |
| Mar 2024 | - | $4.38 M(-18.7%) |
| Dec 2023 | $25.87 M(-6.4%) | $5.39 M(-21.4%) |
| Sep 2023 | - | $6.86 M(+8.9%) |
| Jun 2023 | - | $6.30 M(-13.9%) |
| Mar 2023 | - | $7.32 M(-17.3%) |
| Dec 2022 | $27.66 M(+23.5%) | $8.85 M(+36.8%) |
| Sep 2022 | - | $6.47 M(+11.8%) |
| Jun 2022 | - | $5.79 M(-11.8%) |
| Mar 2022 | - | $6.56 M(+9.6%) |
| Dec 2021 | $22.39 M(+110.5%) | $5.99 M(-0.2%) |
| Sep 2021 | - | $6.00 M(-1.7%) |
| Jun 2021 | - | $6.10 M(+41.7%) |
| Mar 2021 | - | $4.30 M(+35.9%) |
| Dec 2020 | $10.64 M(+9.9%) | $3.17 M(+23.2%) |
| Sep 2020 | - | $2.57 M(+4.0%) |
| Jun 2020 | - | $2.47 M(+2.0%) |
| Mar 2020 | - | $2.42 M(-13.2%) |
| Dec 2019 | $9.68 M(-0.2%) | $2.79 M(+19.0%) |
| Sep 2019 | - | $2.35 M(+0.5%) |
| Jun 2019 | - | $2.34 M(+6.0%) |
| Mar 2019 | - | $2.20 M(-15.7%) |
| Dec 2018 | $9.70 M(+2.2%) | $2.62 M(+6.5%) |
| Sep 2018 | - | $2.46 M(-0.4%) |
| Jun 2018 | - | $2.46 M(+14.0%) |
| Mar 2018 | - | $2.16 M(-1.6%) |
| Dec 2017 | $9.49 M(-36.7%) | $2.20 M(+4.1%) |
| Sep 2017 | - | $2.11 M(-15.1%) |
| Jun 2017 | - | $2.49 M(-7.6%) |
| Mar 2017 | - | $2.69 M(-21.9%) |
| Dec 2016 | $14.99 M(-17.2%) | $3.45 M(-6.4%) |
| Sep 2016 | - | $3.68 M(-7.5%) |
| Jun 2016 | - | $3.98 M(+2.5%) |
| Mar 2016 | - | $3.88 M(-9.3%) |
| Dec 2015 | $18.11 M(-25.1%) | $4.28 M(+4.2%) |
| Sep 2015 | - | $4.11 M(+5.0%) |
| Jun 2015 | - | $3.91 M(-32.7%) |
| Mar 2015 | - | $5.81 M(-3.6%) |
| Dec 2014 | $24.17 M(+26.8%) | $6.03 M(-5.9%) |
| Sep 2014 | - | $6.41 M(+8.0%) |
| Jun 2014 | - | $5.93 M(+2.2%) |
| Mar 2014 | - | $5.81 M(+35.9%) |
| Dec 2013 | $19.06 M | $4.27 M(-30.0%) |
| Sep 2013 | - | $6.10 M(+38.2%) |
| Jun 2013 | - | $4.42 M(+3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $4.26 M(-8.5%) |
| Dec 2012 | $15.17 M(-3.7%) | $4.66 M(+30.9%) |
| Sep 2012 | - | $3.56 M(-7.2%) |
| Jun 2012 | - | $3.84 M(+23.2%) |
| Mar 2012 | - | $3.12 M(-13.6%) |
| Dec 2011 | $15.75 M(+3.3%) | $3.61 M(-7.0%) |
| Sep 2011 | - | $3.88 M(-2.1%) |
| Jun 2011 | - | $3.96 M(-20.6%) |
| Mar 2011 | - | $4.99 M(+167.5%) |
| Dec 2010 | $15.25 M(-19.1%) | $1.87 M(-55.1%) |
| Sep 2010 | - | $4.16 M(-7.7%) |
| Jun 2010 | - | $4.50 M(-4.6%) |
| Mar 2010 | - | $4.72 M(+4.9%) |
| Dec 2009 | $18.85 M(-45.6%) | $4.50 M(+20.2%) |
| Sep 2009 | - | $3.75 M(-27.4%) |
| Jun 2009 | - | $5.16 M(-5.2%) |
| Mar 2009 | - | $5.44 M(+480.3%) |
| Dec 2008 | $34.65 M(+11.4%) | $938.00 K(-93.2%) |
| Sep 2008 | - | $13.71 M(+37.0%) |
| Jun 2008 | - | $10.01 M(+1.5%) |
| Mar 2008 | - | $9.86 M(-4.7%) |
| Dec 2007 | $31.11 M(-7.2%) | $10.35 M(+48.4%) |
| Sep 2007 | - | $6.97 M(+7.2%) |
| Jun 2007 | - | $6.50 M(-1.6%) |
| Mar 2007 | - | $6.61 M(-3.8%) |
| Dec 2006 | $33.52 M(+58.6%) | $6.87 M(+4.6%) |
| Sep 2006 | - | $6.57 M(-19.5%) |
| Jun 2006 | - | $8.16 M(-31.5%) |
| Mar 2006 | - | $11.92 M(+121.5%) |
| Dec 2005 | $21.13 M(-20.5%) | $5.38 M(+37.4%) |
| Sep 2005 | - | $3.92 M(-31.3%) |
| Jun 2005 | - | $5.70 M(-7.0%) |
| Mar 2005 | - | $6.13 M(-21.4%) |
| Dec 2004 | $26.57 M(+47.6%) | $7.80 M(+13.5%) |
| Sep 2004 | - | $6.88 M(+11.8%) |
| Jun 2004 | - | $6.15 M(+7.0%) |
| Mar 2004 | - | $5.75 M(+20.2%) |
| Dec 2003 | $18.01 M(-8.3%) | $4.78 M(+19.5%) |
| Sep 2003 | - | $4.00 M(-25.5%) |
| Jun 2003 | - | $5.37 M(+39.4%) |
| Mar 2003 | - | $3.85 M |
| Dec 2002 | $19.64 M(-1.3%) | - |
| Dec 2001 | $19.91 M(+45.7%) | - |
| Dec 2000 | $13.66 M(-99.8%) | - |
| Jan 1994 | $6.70 B(+0.7%) | - |
| Jan 1993 | $6.65 B | - |
FAQ
- What is Cyclacel Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual total expenses year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly total expenses year-on-year change?
What is Cyclacel Pharmaceuticals annual total expenses?
The current annual total expenses of CYCC is $25.87 M
What is the all time high annual total expenses for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual total expenses is $6.70 B
What is Cyclacel Pharmaceuticals annual total expenses year-on-year change?
Over the past year, CYCC annual total expenses has changed by -$1.78 M (-6.45%)
What is Cyclacel Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of CYCC is $2.19 M
What is the all time high quarterly total expenses for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly total expenses is $13.71 M
What is Cyclacel Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, CYCC quarterly total expenses has changed by -$3.20 M (-59.43%)